» Articles » PMID: 22174901

Genome-wide Association Study of Hepatocellular Carcinoma in Southern Chinese Patients with Chronic Hepatitis B Virus Infection

Overview
Journal PLoS One
Date 2011 Dec 17
PMID 22174901
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

One of the most relevant risk factors for hepatocellular carcinoma (HCC) development is chronic hepatitis B virus (HBV) infection, but only a fraction of chronic HBV carriers develop HCC, indicating that complex interactions among viral, environmental and genetic factors lead to HCC in HBV-infected patients. So far, host genetic factors have incompletely been characterized. Therefore, we performed a genome-wide association (GWA) study in a Southern Chinese cohort consisting of 95 HBV-infected HCC patients (cases) and 97 HBV-infected patients without HCC (controls) using the Illumina Human610-Quad BeadChips. The top single nucleotide polymorphisms (SNPs) were then validated in an independent cohort of 500 cases and 728 controls. 4 SNPs (rs12682266, rs7821974, rs2275959, rs1573266) at chromosome 8p12 showed consistent association in both the GWA and replication phases (OR(combined) = 1.31-1.39; p(combined) = 2.71 × 10(-5)-5.19 × 10(-4); PAR(combined) = 26-31%). We found a 2.3-kb expressed sequence tag (EST) in the region using in-silico data mining and verified the existence of the full-length EST experimentally. The expression level of the EST was significantly reduced in human HCC tumors in comparison to the corresponding non-tumorous liver tissues (P<0.001). Results from sequence analysis and in-vitro protein translation study suggest that the transcript might function as a long non-coding RNA. In summary, our study suggests that variations at chromosome 8p12 may promote HCC in patients with HBV. Further functional studies of this region may help understand HBV-associated hepatocarcinogenesis.

Citing Articles

Genetic Susceptibility to Hepatocellular Carcinoma in Patients with Chronic Hepatitis Virus Infection.

Yang T, Chan C, Yang P, Huang Y, Lee M Viruses. 2023; 15(2).

PMID: 36851773 PMC: 9964813. DOI: 10.3390/v15020559.


HIV-1-Mediated Acceleration of Oncovirus-Related Non-AIDS-Defining Cancers.

Proulx J, Ghaly M, Park I, Borgmann K Biomedicines. 2022; 10(4).

PMID: 35453518 PMC: 9024568. DOI: 10.3390/biomedicines10040768.


Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study.

Wang Z, Budhu A, Shen Y, Wong L, Hernandez B, Tiirikainen M JGH Open. 2021; 5(12):1363-1372.

PMID: 34950780 PMC: 8674550. DOI: 10.1002/jgh3.12682.


Fine Mapping of the MHC Region Identifies Novel Variants Associated with HBV-Related Hepatocellular Carcinoma in Han Chinese.

Mai H, Chen J, Chen H, Liu Z, Huang G, Wang J J Hepatocell Carcinoma. 2021; 8:951-961.

PMID: 34430511 PMC: 8378933. DOI: 10.2147/JHC.S321919.


The association of lncRNA SNPs and SNPs-environment interactions based on GWAS with HBV-related HCC risk and progression.

Liu Q, Liu G, Lin Z, Lin Z, Tian N, Lin X Mol Genet Genomic Med. 2021; 9(2):e1585.

PMID: 33432784 PMC: 8077159. DOI: 10.1002/mgg3.1585.


References
1.
Chan K, Lee J, Guan X, Fan S, Ng I . High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation. Cancer. 2002; 94(12):3179-85. DOI: 10.1002/cncr.10612. View

2.
Su W, Chao C, Yeh S, Chen D, Chen P, Jou Y . OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci. Nucleic Acids Res. 2006; 35(Database issue):D727-31. PMC: 1669730. DOI: 10.1093/nar/gkl845. View

3.
Panzitt K, Tschernatsch M, Guelly C, Moustafa T, Stradner M, Strohmaier H . Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology. 2007; 132(1):330-42. DOI: 10.1053/j.gastro.2006.08.026. View

4.
Tseng C, Tang K, Lo H, Ker C, Teng H, Huang C . UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age. Am J Gastroenterol. 2005; 100(8):1758-63. DOI: 10.1111/j.1572-0241.2005.41857.x. View

5.
Lavanchy D . Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11(2):97-107. DOI: 10.1046/j.1365-2893.2003.00487.x. View